$599

Lilly Licenses GLP-2 from Hanmi; MannKind Pediatric Indication; Signos Raises $20M; Oura Ring GLP-1RA Feature; Apple Advances BG Monitoring?

A series of cardiometabolic-related news items has been observed from Hanmi/Lilly, MannKind, Signos, Oura Ring, and Apple. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here